Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of generic dapagliflozin 10 mg vs Forxiga 10 mg in healthy Thai volunteers (fasting)
TCTR20220908007Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of dapagliflozin (2 arms), sponsored by International Bio Service. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
dapagliflozin
Beyond the preview
Go deeper on TCTR20220908007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220908007.